S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer
Clinical trial NCT03823118 · COMPLETED
Trial details
- NCT number
- NCT03823118
- Sponsor
- Taizhou Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2020-06-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.